期刊文献+

拉帕替尼诱导人鼻咽癌CNE-2Z细胞周期阻滞和细胞凋亡观察 被引量:3

Lapatinib induced cell cycle arrest and apoptosis in CNE-2Z cells
下载PDF
导出
摘要 目的探讨拉帕替尼对人鼻咽癌CNE-2Z细胞周期和凋亡的影响及其作用机制。方法采用CCK-8法检测拉帕替尼对CNE-2Z细胞增殖的影响,PI染色后以流式细胞术进行细胞周期分析,Annexin V/PI双标记法检测细胞凋亡,实时定量PCR检测细胞周期相关分子Cyclin D1、P21和P53的m RNA表达水平,Western blotting检测Cyclin D1、P21、P53及凋亡相关蛋白Mcl-1和Bax的表达,利用Apo-ONE Homogeneous caspase-3/7检测试剂盒检测Caspase-3/7酶活性。结果拉帕替尼呈剂量依赖性地抑制CNE-2Z细胞增殖,并可诱导CNE-2Z细胞发生明显的细胞周期G0/G1期阻滞,促进细胞凋亡,下调Cyclin D1并上调P21、P53 m RNA和蛋白表达,下调Mcl-1和上调Bax蛋白表达,并诱导CNE-2Z细胞内caspase-3/7激活。结论拉帕替尼可有效抑制人鼻咽癌CNE-2Z细胞增殖,诱导细胞周期阻滞并促进其凋亡,可作为治疗鼻咽癌的潜在药物。 Objective To explore the effect oflapatinib on the cell cycle and apoptosis of human CNE-2Z nasopharyngeal carcinoma (NPC) cells, and to study the related mechanisms. Methods CCK-8 assay was used to assess the proliferation of CNE- 2Z cells treated by lapatinib. After PI staining, the cell cycle distribution was determined by flow cytometry. Apoptosis was analyzed using Annexin V/PI double binding assay. The mRNA expression of cell cycle related molecular Cyclin D 1, P21 and P53 was assessed with real time PCR. The expression of protein Cyclin D1, P21, P53, and apoptosis related protein Mcl-1 and Bax was determined by Western blotting. The enzymatic activity of caspase-3/7 was measured by using Apo-ONE Homogeneous Caspase-3/7 Assay kit. Results Lapatinib inhibited the proliferation of CNE-2Z cells in a dose-dependent manner. Various concentrations of lapatinib induced significant G0/G1 phase arrest and promoted apoptosis of CNE-2Z cells. Lapatinib significantly down-regulated Cyclin D1 expression, but up-regulated P21 and P53 expression at mRNA and protein levels. Lapatinib also induced down-regulation of Mcl- 1 with up-regulation of Bax protein expression, and activated Caspase-3/7 in CNE-2Z cells. Conclusion Lapatinib may effectively inhibit proliferation, induce cell cycle arrest and promote apoptosis of CNE-2Z ceils, so it may serve as a potent therapeutic agent against nasopharyngeal carcinoma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2015年第7期568-573,共6页 Medical Journal of Chinese People's Liberation Army
基金 安徽省"十二五"中医临床学术和技术带头人才培养对象基金(2011-539)~~
关键词 拉帕替尼 鼻咽肿瘤 细胞周期 细胞凋亡 lapatinib nasopharyngeal carcinoma cell cycle apoptosis
  • 相关文献

参考文献14

  • 1Teo PM, Kwan WH, Lee WY, et al. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma [J]. Cancer, 1996, 77(12): 2423-2431.
  • 2Ma BB, Poon TC, To KF, et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma-a prospective study[J]. Head Neck, 2003, 25(10): 864-872.
  • 3Chua DT, Nicholls JM, Sham JS, et al. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 59 ( 1 ): 1 1-20.
  • 4Baselga J. Targeting tyrosine kinases in cancer: the second wave[J]. Science, 2006, 312(5777): 1175-1178.
  • 5Ahn ER, Vogel CL. Dual HER2-targeted approaches in HER2- positive breast cancer [J]. Breast Cancer Res Treat, 2012, 131 (2): 371-383.
  • 6Komoto M, Nakata B, Nishii T, et al. In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer[J]. Cancer Sci, 2010, 101(2): 468-473.
  • 7. Mimura K, Kono K, Maruyama T, et al. Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody:dependent cellular cytotoxicity of EGFR- and HER2- overexpressing esophageal cancer cell lines[J]. Int J Cancer, 2011, 129(10): 2408-2416.
  • 8Lui VW, Lau CP, Ho K, et al. Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells[J]. Invest New Drugs, 2011, 29(6): 1241-1252.
  • 9Sherr CJ, Roberts JM. Living with or without cyclins and cyclin- dependent kinases [J]. Genes Dev, 2004, 18 (22): 2699-2711.
  • 10Poon RY. DNA damage checkpoints in nasopharyngeal carcinoma [J]. Oral Oncol, 2014, 50(5): 339-344.

二级参考文献17

共引文献13

同被引文献18

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部